## Wait, What? The Spliceosome Is Rebuilt for Almost Every Intron—and Its Active Site Is Mostly RNA
A eukaryotic pre-mRNA can contain many introns.
The spliceosome must remove each one with extraordinary precision.
But there is no permanent “splicing enzyme” sitting ready like a protease.
Instead, a giant ribonucleoprotein machine assembles on the transcript, rearranges repeatedly, performs two catalytic reactions and then disassembles.
Its major snRNP building blocks are U1, U2, U4, U5 and U6.
The central surprise is that the catalytic core is built largely from **U2 and U6 snRNA**, supported by proteins such as Prp8.
The spliceosome is therefore best understood as a **protein-directed metalloribozyme**.
## The One-Sentence Answer
**Learn the spliceosome as a dynamic RNA-catalytic state machine: U1 identifies the 5′ splice site, U2 recognizes the branch region, the U4/U6.U5 tri-snRNP joins, ATP-dependent rearrangements eject U1 and U4 so U2/U6 can build the catalytic metal-binding RNA core, the branch-point adenosine performs the first transesterification, the 5′ exon performs the second, and Prp2/Prp16/Prp22/Prp43 remodel and proofread the machine before mRNA release and snRNP recycling.**
## Learning Ladder
**Beginner:** the spliceosome removes introns and joins exons in pre-mRNA.
**Secondary / Pre-University:** genes, exons, introns, RNA, base pairing, ATP and mRNA processing.
**Undergraduate:** U1, U2, U4/U6.U5 tri-snRNP, branch point, 5′/3′ splice sites, Prp8, Brr2, Prp2, Prp16, Prp22 and Prp43.
**Advanced / Professional:** E/A/pre-B/B/Bact/B*/C/C*/P/ILS states, SF3B1 branch-site closure, U2/U6 catalytic triplex, metal-ion catalysis, ATPase kinetic proofreading, exon alignment by U5 loop I, discard pathways and co-transcriptional assembly.
—
## Stage 1: Begin With the Sequence Problem
A pre-mRNA contains exons that should remain and introns that should be removed.
The spliceosome must identify boundaries accurately.
A one-nucleotide error can alter protein sequence, change reading frame or create a premature stop codon.
## Stage 2: Splice Sites Are Signals, Not Perfect Barcodes
Major introns often contain a 5′ splice-site consensus, branch-point sequence, polypyrimidine tract and 3′ splice site.
These motifs are variable.
The spliceosome recognizes combinations of weak signals.
## Stage 3: U1 Recognizes the 5′ Splice Site
U1 snRNA base-pairs with the 5′ splice-site region.
This creates an early commitment step.
But U1 is not part of the final catalytic active site.
It will later be displaced.
## Stage 4: The Branch Point Is the Future Nucleophile
Near the 3′ end of the intron lies a branch-point adenosine.
Its 2′-OH group will perform the first chemical attack.
The branch-point base must therefore be selected before catalysis.
## Stage 5: U2 snRNP Recognizes the Branch Region
U2 snRNA base-pairs with the branch-site sequence.
The branch-point adenosine is bulged out rather than paired normally.
This geometry prepares its 2′-OH for chemistry.
## Stage 6: SF3B1 Helps Clamp the Branch Region
SF3B1 is part of the SF3b module within U2 snRNP.
Its HEAT-repeat architecture closes around the branch-site region during stable recognition.
This protects and verifies the U2–branch interaction before activation.
## Stage 7: PRP5 Helps Proofread Branch-Site Selection
PRP5 is an ATPase/helicase-family factor.
Recent structures show it participates in rearranging U2 snRNA and testing branch-site engagement.
Branch selection is therefore a kinetic proofreading step, not mere base pairing.
## Stage 8: The A Complex Contains Committed U1 and U2 Interactions
Once U1 and U2 are positioned productively, the prespliceosome or **A complex** forms.
The intron has been identified.
It is not yet catalytically active.
## Stage 9: The U4/U6.U5 Tri-snRNP Joins
The tri-snRNP is a large preassembled complex containing U4, U6 and U5 snRNPs.
Its arrival forms pre-B/B-type states.
The catalytic machinery is now physically present but still restrained.
## Stage 10: U4 Holds U6 Inactive
U4 and U6 snRNAs are extensively base-paired.
This keeps U6 from forming the catalytic RNA structures it will need later.
U4 therefore acts like a temporary inhibitory chaperone.
## Stage 11: U5 Is Positioned to Align Exons
U5 snRNA loop I interacts with exon sequences.
Prp8 surrounds the catalytic centre and helps position U5.
The future exon-ligation geometry is prepared before the first chemistry occurs.
## Stage 12: The Spliceosome Must Replace U1 With U6 at the 5′ Site
U1 was excellent for early recognition.
But U6 must eventually contact the 5′ splice site in the catalytic core.
An ATP-dependent rearrangement replaces one RNA–RNA interaction with another.
## Stage 13: Prp28 Helps Displace U1
Prp28-family ATPase activity remodels the 5′ splice-site region.
U1 leaves.
U6 can engage the site.
Early recognition machinery is sacrificed to create catalytic geometry.
## Stage 14: Brr2 Unwinds U4/U6
Brr2 is a large helicase associated with U5/Prp8.
It unwinds U4/U6 duplexes.
U4 is released.
U6 is liberated to form catalytic interactions.
## Stage 15: U2 and U6 Build the Catalytic RNA Core
Freed U6 base-pairs with U2.
The resulting RNA structure includes conserved motifs that coordinate catalytic magnesium ions.
The spliceosome’s chemistry therefore resembles ancient self-splicing introns.
## Stage 16: Prp8 Builds the Protein Cavity Around the RNA Active Site
Prp8 is a huge U5 protein.
Its domains surround the catalytic RNA.
It organizes substrates and stabilizes the active centre.
This is why the spliceosome is called a **protein-directed ribozyme** rather than RNA acting alone.
## Stage 17: The Bact Complex Is Activated but Not Yet Chemically Ready
After U1/U4 release and recruitment of NTC-related factors, the **Bact** complex forms.
The RNA catalytic core exists.
But the branch point still needs to move into the exact first-step position.
## Stage 18: Prp2 Drives the Bact-to-B* Transition
Prp2 is a DEAH-box ATPase.
ATP-dependent remodeling displaces branch-region factors including parts of SF3b.
The branch-point adenosine becomes accessible to the catalytic centre.
## Stage 19: Modern Structures Resolved Multiple Human Activation Intermediates
Cryo-EM captured sequential Bact conformations.
These structures show activation is not one sudden jump.
It is a series of ordered translocations and factor-release events.
## Stage 20: The First Chemical Step Is Branching
The branch-point adenosine 2′-OH attacks the phosphate at the 5′ splice site.
This produces a free 5′ exon with a 3′-OH and a lariat intron–3′ exon intermediate.
No ATP is consumed in the bond-exchange chemistry itself.
## Stage 21: The Lariat Contains a 2′–5′ Phosphodiester Bond
The branch-point A becomes linked to the 5′ end of the intron.
This creates the characteristic lariat structure.
It is a unique chemical signature of spliceosomal splicing.
## Stage 22: The Active Site Must Be Reconfigured for Step Two
After branching, the nucleophile for the second reaction is now the **3′-OH of the freed 5′ exon**.
The 3′ splice site must be positioned accurately.
The same catalytic core must change substrate geometry.
## Stage 23: Prp16 Remodels the Post-Branching Spliceosome
Prp16 uses ATP to promote conformational transitions between first and second catalytic steps.
It also contributes to proofreading.
Slow or defective intermediates can be rejected.
## Stage 24: Proofreading Is a Kinetic Competition
If the substrate reaches productive chemistry quickly, splicing proceeds.
If it stalls, ATPases can remodel it into a discard pathway.
The spliceosome therefore uses time as a fidelity signal.
## Stage 25: U5 Loop I Helps Align the Exons
U5 contacts both exon regions.
This helps position the 5′ exon 3′-OH and 3′ splice site.
The second reaction is therefore a geometry problem.
## Stage 26: The Second Chemical Step Ligates the Exons
The 3′-OH of the 5′ exon attacks the phosphate at the 3′ splice site.
Products are mature ligated mRNA and the excised intron lariat.
Again, bond exchange is transesterification.
## Stage 27: Prp22 Helps Second-Step Fidelity and mRNA Release
Prp22 interacts with the 3′ exon region.
It supports exon ligation and later uses ATP hydrolysis to promote mRNA release.
Modern work has refined this dual role.
## Stage 28: ATP Binding and ATP Hydrolysis Can Have Different Prp22 Effects
ATP-bound Prp22 can influence exon-ligation geometry, while ATP hydrolysis drives later release.
Nucleotide state is therefore a multi-step switch.
## Stage 29: Mature mRNA Must Leave the Spliceosome
After exon ligation, the mRNA product remains associated with spliceosomal proteins.
Prp22-driven remodeling helps release it.
Only then can the mRNP proceed efficiently to later processing/export.
## Stage 30: The Intron Lariat Still Occupies a Large Complex
The remaining intron-lariat spliceosome contains expensive snRNP components.
It must be dismantled.
Disassembly is active, not spontaneous.
## Stage 31: Prp43 Drives Spliceosome Disassembly
Prp43 is a DEAH-box ATPase/helicase.
With NTR-related cofactors, it dismantles intron-lariat spliceosomes.
Components return to the free snRNP pool.
## Stage 32: Prp43 Also Helps Discard Defective Spliceosomes
The same disassembly machinery can remove stalled or aberrant intermediates.
Quality control therefore shares machinery with normal recycling.
## Stage 33: U5 Must Be Rebuilt for Another Round
U5 snRNP itself undergoes late biogenesis/recycling with dedicated chaperones.
Recent structures revealed how U5 is prepared to rejoin the next U4/U6.U5 tri-snRNP.
Splicing consumes assembly states, not the snRNP molecules permanently.
## Stage 34: The Spliceosome Is a Molecular State Machine
A simplified sequence is:
> **E → A → pre-B/B → Bact → B* → C → C* → P → ILS → disassembly**
Each state has different RNA pairings, proteins and chemistry.
## Stage 35: ATPases Do Not Power the Transesterification Bonds Directly
The chemical steps exchange phosphodiester bonds without ATP hydrolysis.
ATPases are used for assembly, rearrangement, proofreading, release and disassembly.
Energy is spent on **fidelity and directionality**, not on the bond chemistry itself.
## Stage 36: Alternative Splicing Acts Upstream of the Catalytic Core
Alternative splicing changes which splice sites are selected.
Once a particular intron/exon choice enters a productive catalytic pathway, the same core machinery performs the chemistry.
This preserves the broad alternative-splicing canonical owner.
## Stage 37: SF3B1 Mutations Reveal Branch-Site Selection Fidelity
Cancer-associated SF3B1 variants can shift branch-point usage and activate cryptic 3′ splice sites.
The catalytic machinery can remain functional while **site selection becomes imprecise**.
## Stage 38: Spliceosome Errors Can Feed Into NMD
If abnormal splicing introduces a premature termination codon, nonsense-mediated decay can destroy the resulting mRNA.
Splicing and surveillance are connected sequentially.
They remain mechanistically distinct.
## Stage 39: Co-Transcriptional Splicing Adds Another Timing Layer
Many introns begin spliceosome assembly while RNA polymerase II is still transcribing downstream sequence.
The spliceosome therefore operates in a moving transcriptional landscape.
## Stage 40: The Professional Question Is a Recognition–Catalysis–Proofreading Closure Test
Ask:
> **Which 5′ splice site and branch site were selected, what U1/U2 interactions formed, whether tri-snRNP recruitment and U1/U4 displacement built the U2/U6 catalytic core, which ATPase transition licensed each chemical step, whether both transesterifications used the intended sites, how Prp22 released the mRNA, and whether Prp43 recycled the complex without allowing a slow aberrant substrate to masquerade as correct splicing.**
## Evidence: What Proves What?
### Site recognition
– U1/U2 crosslinking;
– branch-point mapping;
– SF3B1 structures;
– PRP5 mutants.
### Assembly states
– native gels;
– cryo-EM;
– snRNP composition;
– ATPase perturbation.
### Catalysis
– lariat mapping;
– exon-ligation products;
– catalytic-metal studies.
### Proofreading
– Prp16/Prp22 mutants;
– slow-substrate assays;
– cryptic splice-site usage.
### Disassembly
– Prp43/NTR perturbation;
– snRNP recycling;
– lariat-spliceosome accumulation.
## Connections Worth Making
### RNA Processing
The catalytic cycle executes splice-site choices made during transcript processing.
### RNA Catalysis
U2/U6 snRNA creates the metal-dependent catalytic centre.
### Molecular Motors
DEAD/DEAH-box ATPases remodel RNA–protein states.
### Quality Control
Kinetic proofreading rejects slow or incorrect intermediates.
### NMD
Mis-spliced mRNAs can become downstream surveillance substrates.
## Misconceptions Worth Hunting
– **“The spliceosome is one stable enzyme complex.”** It assembles and remodels repeatedly.
– **“U1 stays at the 5′ splice site through catalysis.”** U1 is displaced before the active site forms.
– **“U4 is part of the final catalytic RNA core.”** U4 restrains U6 and is released during activation.
– **“ATP supplies the energy for the two phosphodiester reactions.”** ATPases remodel and proofread; transesterification itself does not require ATP hydrolysis.
– **“Proteins alone form the catalytic active site.”** U2/U6 RNA coordinates catalytic metals.
– **“Prp16 and Prp22 only move RNA.”** They also contribute to fidelity.
– **“Alternative splicing is the same thing as spliceosome catalysis.”** Site choice and chemistry are separable layers.
– **“Splicing ends when exons are joined.”** mRNA release and complex disassembly remain.
## Transfer Check
U1 recognizes the 5′ splice site but cannot be displaced. Can the normal U6 catalytic interaction form? **No.**
Brr2 cannot unwind U4/U6. What state remains blocked? **Catalytic activation.**
Prp2 ATPase activity is lost after Bact formation. What major transition fails? **Exposure/positioning of the branch point for first-step catalysis.**
The first transesterification occurs but Prp16-dependent remodeling fails. Can second-step geometry become defective? **Yes.**
Exons are ligated but Prp22 cannot hydrolyse ATP. What downstream event is impaired? **Efficient mRNA release.**
## How We Know the Learning Has Held
A learner should be able to explain U1 and U2 recognition; define the branch-point adenosine; explain tri-snRNP recruitment; explain U1/U4 displacement; describe U2/U6 catalysis; explain the two transesterification steps; explain Prp2, Prp16, Prp22 and Prp43; distinguish ATPase remodeling from catalytic chemistry; connect SF3B1 with branch-site fidelity; and distinguish catalytic splicing from alternative-splicing regulation and NMD.
## Model Limits
Human and yeast spliceosomes are deeply related but not identical. State nomenclature can differ between studies. Many cryo-EM structures trap selected intermediates rather than continuous motion. ATPase proofreading models are strongest in specific experimental systems. Co-transcriptional assembly changes kinetics relative to purified in-vitro splicing. Minor spliceosomes use related but distinct snRNPs.
> **Professional spliceosome science keeps splice-site identity + snRNP composition + RNA-pairing state + ATPase state + catalytic geometry + proofreading timer + product-release state visible together.**
## Teaching Guide
Teach in this order:
**5′ splice site → U1 → branch point → U2/SF3B1/PRP5 → A complex → tri-snRNP → U1 displacement → U4/U6 unwinding → U2/U6 catalytic core → Prp2 → first step → Prp16 → second step → Prp22 → mRNA release → Prp43 → recycling → model limits.**
Begin with:
> “If the spliceosome’s active site is built only after several RNA particles arrive, why does the cell first bind U1 to a site that U1 must later abandon?”
## Connect This to the eduKate Learning Estate
– [RNA Processing and Alternative Splicing](
https://edukatesengkang.com/2026/08/29/how-to-learn-rna-processing-alternative-splicing/)
– [Gene Expression and Protein Synthesis](
https://edukatesengkang.com/2026/08/28/how-to-learn-gene-expression-protein-synthesis-dna-cellular-regulation/)
– [Nonsense-Mediated mRNA Decay](
https://edukatesengkang.com/2026/09/01/how-to-learn-nonsense-mediated-mrna-decay/)
– [Bacterial RNA Degradosome](
https://edukatesengkang.com/2026/08/31/how-to-learn-bacterial-rna-degradosome/)
These remain broader or adjacent canonical owners. This article owns **the major spliceosome’s molecular assembly, catalytic, proofreading and disassembly cycle**.
## Research Foundations and Further Learning
– Structural reviews of the spliceosome as a protein-directed metalloribozyme.
– Human U2 snRNP and SF3B1 branch-site structures.
– Recent structures of multiple human Bact activation intermediates.
– Structural work on branch-site proofreading by PRP5.
– U4/U6.U5 tri-snRNP cryo-EM and Brr2 activation studies.
– U5 snRNP recycling structures.
– Mechanistic work on Prp22 in exon ligation and mRNA release.
## The Quiet Ending
The beginner asks:
“How does the cell cut introns out without cutting exons?”
The developing RNA biologist asks:
“Why does U4 have to leave before U6 can work?”
The advanced learner asks:
“How can ATPase timing improve splice-site fidelity if ATP does not power the splicing reaction itself?”
And the professional asks:
> **Can we reconstruct one intron’s complete molecular trajectory from recognition to mRNA release while proving which ATP-driven checkpoint rejected incorrect alternatives before chemistry became irreversible?**